Corrigendum to "Autoimmune channelopathies: John Newsom-Davis's work and legacy: A summary of the Newsom-Davis Memorial Lecture 2008" [J. Neuroimmunol. 201-202 (2008) 245-249] (DOI:10.1016/j.jneuroim.2008.07.007);Autoimmune channelopathies: John Newsom-Davis's work and legacy. A summary of the Newsom-Davis Memorial Lecture 2008

Journal of Neuroimmunology

Volumn 201-202, Issue C, 2008, Pages 245-249

  Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

aetylcholine receptors; aquaporins; autoantibody; calcium channels; developmental disorders; encephalopathies; glutamate receptors; ion channels; Lambert Eaton myasthenic syndrome; maternal to fetal transfer; Myasthenia; neuromyotonia; potassium channels; receptors

Indexed keywords

VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; EATON LAMBERT SYNDROME; HUMAN; MYASTHENIA; MYASTHENIA GRAVIS; MYOKYMIA; NEUROIMMUNOLOGY; NONHUMAN; PATHOGENICITY; PLASMAPHERESIS; PRIORITY JOURNAL;

EID: 51649099918     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.02.014     Document Type: Erratum

References (49)

1. Banwell B., Tenembaum S., Lennon V.A., Ursell E., Kennedy J., Bar-Or A., Weinshenker B.G., Lucchinetti C.F., and Pittock S.J. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 70 (2008) 344-352
2. Benveniste O., Jacobson L., Farrugia M.E., Clover L., and Vincent A. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J. Neuroimmunol. 170 (2005) 41-48
3. Bernasconi P., Cipelletti B., Passerini L., Granata T., Antozzi C., Mantegazza R., and Spreafico R. Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients' sera. Neurology 59 (2002) 1998-2001
4. Bien C.G., Granata T., Antozzi C., Cross J.H., Dulac O., Kurthen M., Lassmann H., Mantegazza R., Villemure J.G., Spreafico R., and Elger C.E. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128 (2005) 454-471
5. Boneva N., Frenkian-Cuvelier M., Bidault J., Brenner T., and Berrih-Aknin S. Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J. Neuroimmunol. 177 (2006) 119-131
6. Buckley C., Oger J., Clover L., Tuzun E., Carpenter K., Jackson M., and Vincent A. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann. Neurol. 50 (2001) 73-78
7. Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Mason W., Sansing L.H., Dichter M.A., Rosenfeld M.R., and Lynch D.R. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 61 (2007) 25-36
8. Dalton P., Deacon R., Blamire A., Pike M., McKinlay I., Stein J., Styles P., and Vincent A. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 53 (2003) 533-537
9. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
10. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330 (1994) 1797-1810
11. Farrugia M.E., Robson M.D., Clover L., Anslow P., Newsom-Davis J., Kennett R., Hilton-Jones D., Matthews P.M., and Vincent A. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 129 (2006) 1481-1492
12. Hart I.K., Maddison P., Newsom-Davis J., Vincent A., and Mills K.R. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 (2002) 1887-1895
13. Hart I.K., Waters C., Vincent A., Newland C., Beeson D., Pongs O., Morris C., and Newsom-Davis J. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann. Neurol. 41 (1997) 238-246
14. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 (2001) 365-368
15. Hutchinson, M., Waters, P., McHugh, J., Gorman, G., O'Riordan, S., Connolly, S., Hager, H., Yu, P., Becker, C.-M., Vincent, A., in press. Progressive encephalomyelitis, rigidity and myoclonus: a novel glycine receptor antibody. Neurology.
16. Irani, S.R., Buckley, C., Vincent, A., Cockerell, C., Rudge, P., Johnson,-M.R., Smith, S., in press. Immunotherapy - responsive seizure - like episodes with potassium channel antibodies. Neurology.
17. Jacobson L., Polizzi A., Morriss-Kay G., and Vincent A. Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. J. Clin. Invest. 103 (1999) 1031-1038
18. Lambert E.H., and Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann. N. Y. Acad. Sci. 183 (1971) 183-199
19. Lang B., Newsom-Davis J., Wray D., Vincent A., and Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 2 (1981) 224-226
20. Lauriola L., Ranelletti F., Maggiano N., Guerriero M., Punzi C., Marsili F., Bartoccioni E., and Evoli A. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64 (2005) 536-538
21. Leite M.I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B.P., Beeson D., Willcox N., and Vincent A. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 131 (2008) 1940-1952
22. Leite M.I., Jones M., Strobel P., Marx A., Gold R., Niks E., Verschuuren J.J., Berrih-Aknin S., Scaravilli F., Canelhas A., Morgan B.P., Vincent A., and Willcox N. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am. J. Pathol. 171 (2007) 893-905
23. Leite M.I., Strobel P., Jones M., Micklem K., Moritz R., Gold R., Niks E.H., Berrih-Aknin S., Scaravilli F., Canelhas A., Marx A., Newsom-Davis J., Willcox N., and Vincent A. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann. Neurol. 57 (2005) 444-448
24. Lennon V.A., Kryzer T.J., Griesmann G.E., O'Suilleabhain P.E., Windebank A.J., Woppmann A., Miljanich G.P., and Lambert E.H. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N. Engl. J. Med. 332 (1995) 1467-1474
25. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202 (2005) 473-477
26. Liguori R., Vincent A., Clover L., Avoni P., Plazzi G., Cortelli P., Baruzzi A., Carey T., Gambetti P., Lugaresi E., and Montagna P. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124 (2001) 2417-2426
27. Majoie H.J., de Baets M., Renier W., Lang B., and Vincent A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 71 (2006) 135-141
28. McKnight K., Jiang Y., Hart Y., Cavey A., Wroe S., Blank M., Shoenfeld Y., Vincent A., Palace J., and Lang B. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65 (2005) 1730-1736
29. McNamara J.O., Whitney K.D., Andrews P.I., He X.P., Janumpalli S., and Patel M.N. Evidence for glutamate receptor autoimmunity in the pathogenesis of Rasmussen encephalitis. Adv. Neurol. 79 (1999) 543-550
30. Mossman S., Vincent A., and Newsom-Davis J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1 (1986) 116-119
31. Motomura M., Johnston I., Lang B., Vincent A., and Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiatry 58 (1995) 85-87
32. Newsom-Davis J., Pinching A.J., Vincent A., and Wilson S.G. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 28 (1978) 266-272
33. Raine C.S. John M Newsom-Davis. J. Neuroimmunol. 194 (2008) 3-4
34. Riemersma S., Vincent A., Beeson D., Newland C., Hawke S., Vernet-der Garabedian B., Eymard B., and Newsom-Davis J. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J. Clin. Invest. 98 (1996) 2358-2363
35. 2+ flux in a human small cell carcinoma line. Nature 317 (1985) 737-739
36. Rogers S.W., Andrews P.I., Gahring L.C., Whisenand T., Cauley K., Crain B., Hughes T.E., Heinemann S.F., and McNamara J.O. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265 (1994) 648-651
37. Shillito P., Molenaar P.C., Vincent A., Leys K., Zheng W., van den Berg R.J., Plomp J.J., van Kempen G.T., Chauplannaz G., Wintzen A.R., et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann. Neurol. 38 (1995) 714-722
38. Singer H.S., Morris C.M., Gause C.D., Gillin P.K., Crawford S., and Zimmerman A.W. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 194 (2008) 165-172
39. Sinha S., Newsom-Davis J., Mills K., Byrne N., Lang B., and Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338 (1991) 75-77
40. Spinazzi, M., Argentiero, V., Zuliani, L., Palmieri, A., Tavolato, B., Vincent, A., in press. Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan Syndrome Neurology.
41. Tan K.M., Lennon V.A., Klein C.J., Boeve B.F., and Pittock S.J. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 70 (2008) 1883-1890
42. Thieben M.J., Lennon V.A., Boeve B.F., Aksamit A.J., Keegan M., and Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62 (2004) 1177-1182
43. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2 (2002) 797-804
44. Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., Clover L., Parkinson A., Bien C.G., Omer S., Lang B., Rossor M.N., and Palace J. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 (2004) 701-712
45. Vincent A., Lang B., and Kleopa K.A. Autoimmune channelopathies and related neurological disorders. Neuron 52 (2006) 123-138
46. Waters P., Jarius, S., Littleton E., Leite M.I., Jacob S., Gray B., Geraldes R., Vale T., Jacob A., Palace J., Maxsell S., Beeson D., and Vincent A. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally-extensive transverse myelitis. Arch. Neurol. 65 (2008) 913-919
47. Watson R., Jiang Y., Bermudez I., Houlihan L., Clover L., McKnight K., Cross J.H., Hart I.K., Roubertie A., Valmier J., Hart Y., Palace J., Beeson D., Vincent A., and Lang B. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 63 (2004) 43-50
48. Wiendl H., Bien C.G., Bernasconi P., Fleckenstein B., Elger C.E., Dichgans J., Mantegazza R., and Melms A. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 57 (2001) 1511-1514
49. Willcox N. John Newsom-Davis 1932-2007. J. Neuroimmunol. 194 (2008) 1-2